Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01341
|
|||||
| Drug Name |
Triamterene
|
|||||
| Synonyms |
Ademin; Ademine; Amteren; Anjal; Dazid; Diarol; Dinazide; Diren; Ditak; Diucelpin; Diurene; Diutensat; Diuteren; Dyberzide; Dyren; Dyrenium; Dytac; Dytenzide; Esiteren; Hidiurese; Hydrene; Hypertorr; Isobar; Jatropur; Jenateren; Kalspare; Masuharmin; Nephral; Noridil; Noridyl; Pterofen; Pterophene; Renezide; Reviten; Taturil; Teriam; Teridin; Triamizide; Triampur; Triamteren; Triamterena; Triamterenum; Triamteril; Triamterine; Triamthiazid; Tricilone; Trispan; Triteren; Triurene; Trizid; Turfa; Uretren; Urocaudal; Goldshield Brand of Triamterene; Jorba Brand of Triamterene; Pter ophene; SmithKline Beecham Brand of Triamterene; TRIAMTERENE USP; Thiazid Wolff; Triamteril complex; Wellspring Brand of Triamterene; Fluss 40; SKF 8542; T 4143; Ademin(e); Apo-triazide; Dyrenium (TN); Pteridine deriv. 11; SALI-PUREN; SK&F 8542; SK-8542; Tri-Span; Triamterena [INN-Spanish]; Triamterenum [INN-Latin]; SK&F-8542; Triamterene (JP15/USP/INN); Triamterene [USAN:INN:BAN:JAN]; 2,4,7-Triamino-6-fenilpteridina; 2,4,7-Triamino-6-fenilpteridina [Italian]; 2,4,7-Triamino-6-phenylpteridine; 6-PHENYL-2,4,7-TRIAMINO PTERIDINE; 6-Phenyl-2,4,7-pteridinetriamine; 6-Phenyl-2,4,7-triaminopteridine; 6-phenylpteridine-2,4,7-triamine
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Edema associated with congestive heart failure [ICD11: BD10] | Approved | [1] | |||
| Therapeutic Class |
Diuretics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C12H11N7
|
|||||
| Canonical SMILES |
C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N
|
|||||
| InChI |
InChI=1S/C12H11N7/c13-9-7(6-4-2-1-3-5-6)16-8-10(14)18-12(15)19-11(8)17-9/h1-5H,(H6,13,14,15,17,18,19)
|
|||||
| InChIKey |
FNYLWPVRPXGIIP-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 396-01-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 253.26 | Topological Polar Surface Area | 130 | ||
| Heavy Atom Count | 19 | Rotatable Bond Count | 1 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
1
|
|||||
| PubChem CID | ||||||
| PubChem SID |
118408
, 602599
, 855896
, 933823
, 5660597
, 7847452
, 8036221
, 8149565
, 8153414
, 10321477
, 11111878
, 11111879
, 11335608
, 11360847
, 11363402
, 11365964
, 11368526
, 11372243
, 11373970
, 11376688
, 11452214
, 11461819
, 11466062
, 11467182
, 11484612
, 11485784
, 11488754
, 11491187
, 11492181
, 11494322
, 14774401
, 17389703
, 17405750
, 24277877
, 26611958
, 26679801
, 26747035
, 26751552
, 29224587
, 46507623
, 47291080
, 47588940
, 47662218
, 47662219
, 47810690
, 47885351
, 47885352
, 47959674
, 48035047
, 48334426
|
|||||
| ChEBI ID |
CHEBI:9671
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OCT-1 | Transporter Info | Organic cation transporter 1 | Substrate | [2] | |
| References | ||||||
| 1 | Triamterene was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2. J Med Chem. 2013 Sep 26;56(18):7232-42. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.